Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NXT USA is a private nutraceutical ingredients company that develops and commercializes clinically validated branded natural ingredients for wellness products. Its portfolio includes TamaFlex for joint health, Digexin for digestive and gut-brain support, Xeya Modern Shatavari for women's hormonal health including PCOS and menopause-related symptoms, and BluNAD Booster for healthy aging and NAD+ support. The company positions itself as a science-driven B2B partner to supplement and functional product manufacturers, emphasizing human clinical studies, formulation support, and reliable global sourcing. NXT USA is not a drug-development biotech company; it operates in the broader health and nutraceutical sector with commercial-stage branded ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NXT USA.